Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Lantern Pharma, Inc. (LTRN)
NASDAQ:LTRN
Lantern Pharma (LTRN) Ownership Overview
22.88% Insiders
4.33% Mutual Funds
15.08% Other Institutional Investors
3.78% ETFs
53.94% Public Companies and Individual Investors
The ownership structure of Lantern Pharma (LTRN) stock is a mix of institutional, retail, and individual investors. Approximately 23.18% of the company’s stock is owned by Institutional Investors, 22.88% is owned by Insiders, and 53.94% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
| Jul 26, 2024 | Jeffrey Keyser Director | xxxxxxxxxxxxx | $11994 |
| May 28, 2024 | Aaron G.l. Fletcher Director, >10% Owner | xxxxxxxxxxxxx | $189100 |
| May 28, 2024 | Leslie W. Kreis Director, >10% Owner | xxxxxxxxxxxxx | $189100 |
| Feb 29, 2024 | Aaron G.l. Fletcher Director, >10% Owner | xxxxxxxxxxxxx | $676294 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 1,233,802 | Insider | 11.44% | 5,959,264 | |
| 1,233,802 | Insider | 11.44% | 5,959,264 | |
| 355,378 | Institution | 3.30% | 1,716,476 | |
| 355,378 | Institution | 3.30% | 1,716,476 | |
| 78,913 | Institution | 0.73% | 381,150 | |
| 28,791 | Institution | 0.27% | 139,061 | |
| 25,531 | Institution | 0.24% | 123,315 | |
| 17,014 | Institution | 0.16% | 82,178 | |
| 10,000 | Institution | 0.09% | 48,300 | |
| 6,129 | Institution | 0.06% | 29,603 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 355,378 | Institution | 3.30% | 1,716,476 | |
| 78,913 | Institution | 0.73% | 381,150 | |
| 25,531 | Institution | 0.24% | 123,315 | |
| 5,987 | Institution | 0.06% | 28,917 | |
| 766 | Institution | <0.01% | 3,700 | |
| 174 | Institution | <0.01% | 840 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 256,113 | Institution | 2.37% | 817,000 | |
| 99,265 | Institution | 0.92% | 316,655 | |
| 28,791 | Institution | 0.27% | 138,485 | |
| 17,014 | Institution | 0.16% | 82,178 | |
| 3,155 | Institution | 0.03% | 15,176 | |
| 1,924 | Institution | 0.02% | 9,254 | |
| 1,042 | Institution | <0.01% | 5,012 | |
| 4 | Institution | <0.01% | 19 | |
| 4 | Institution | <0.01% | 19 |
FAQ
Who Owns Lantern Pharma, Inc. (LTRN)?
According to the latest TipRanks data, approximately 15.08% of the company's stock is held by institutional investors, 22.88% is held by insiders, and 53.94% is held by retail investors.
What percentage of Lantern Pharma, Inc. (LTRN) stock is held by institutional investors?
According to the latest TipRanks data, approximately 15.08% of Lantern Pharma, Inc. (LTRN) stock is held by institutional investors.
What percentage of Lantern Pharma, Inc. (LTRN) stock is held by retail investors?
According to the latest TipRanks data, approximately 53.94% of Lantern Pharma, Inc. (LTRN) stock is held by retail investors.
Who owns the most shares of Lantern Pharma, Inc. (LTRN)?
Leslie W. Kreis owns the most shares of Lantern Pharma, Inc. (LTRN).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.